Description: HLB Co., Ltd. manufactures pharmaceutical products, and builds ships. It manufactures and sells various types of lifeboats for marine plants, drill ships, and cruise vessels in South Korea. The company offers conventional type lifeboats, free fall type lifeboats, and rescue boats. It also provides marine and yacht engines; hooks; RIB, patrol, fishing, aluminum, and leisure boats; fishery inspection ships; and safety goods, as well as lifeboat and davit inspection and repair services, service engineering training, and spare parts for lifeboats and davits. In addition, the company develops Riboseranib, a targeted anti-cancer agent; and Apilia that is used for the treatment for ovarian cancer. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.
Home Page: www.hlbkorea.com
216-53, Dangwol-ro
Ulsan,
135-816
South Korea
Phone:
82 5 2240 3500
Officers
| Name | Title |
|---|---|
| Mr. Jung-Min Park | Chief Exec. Officer & Representative Director |
| Mr. Sung-Chul Kim | Head of Bio Department & Inside Director |
Exchange: KQ
Country: KR
Currency: Korean Won (₩)
| GIC Sector: | Consumer Discretionary |
|---|---|
| GIC Group: | Consumer Durables & Apparel |
| GIC Industry: | Leisure Products |
| GIC Sub-Industry: | Leisure Products |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 7.1904 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |